Epigenetics, stem cells and epithelial cell fate

Differentiation

Volumn 78, Issue 2-3, 2009, Pages 99-107

  Vincent, Audrey ^a   Van Seuningen, Isabelle ^a  

^a JEAN PIERRE AUBERT RESEARCH CENTER   (France)

Author keywords

Cancer; Differentiation; Embryogenesis; Epigenetics; Histone modifications; Intestinal crypts; Methylation; Stem cells

Indexed keywords

DNA METHYLTRANSFERASE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE METHYLTRANSFERASE;

ARTICLE; BLOOD CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL TYPE; DEVELOPMENT; DIGESTIVE SYSTEM; EPIGENETICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; MESENCHYME CELL; MUSCLE CELL; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TUMOR;

ANIMALS; CELL DIFFERENTIATION; EPIGENESIS, GENETIC; EPITHELIAL CELLS; HUMANS; STEM CELLS;

EID: 70249104155     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2009.07.002     Document Type: Article

References (119)

1. Agger K., Christensen J., Cloos P.A., and Helin K. The emerging functions of histone demethylases. Curr. Opin. Genet. Dev. 18 (2008) 159-168
2. Akiyama Y., Watkins N., Suzuki H., Jair K.W., van Engeland M., Esteller M., Sakai H., Ren C.Y., Yuasa Y., Herman J.G., and Baylin S.B. GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol. Cell. Biol. 23 (2003) 8429-8439
3. Amoh Y., Li L., Katsuoka K., and Hoffman R.M. Multipotent hair follicle stem cells promote repair of spinal cord injury and recovery of walking function. Cell Cycle 7 (2008) 1865-1869
4. Augenlicht L., Shi L., Mariadason J., Laboisse C., and Velcich A. Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation. Oncogene 22 (2003) 4983-4992
5. Bach S.P., Renehan A.G., and Potten C.S. Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis 21 (2000) 469-476
6. Balhorn R. The protamine family of sperm nuclear proteins. Genome Biol. 8 (2007) 227
7. Bannister A.J., Zegerman P., Partridge J.F., Miska E.A., Thomas J.O., Allshire R.C., and Kouzarides T. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410 (2001) 120-124
8. Barker N., and Clevers H. Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology 133 (2007) 1755-1760
9. Barker N., Ridgway R.A., van Es J.H., van de Wetering M., Begthel H., van den Born M., Danenberg E., Clarke A.R., Sansom O.J., and Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457 (2009) 608-611
10. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., and Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449 (2007) 1003-1007
11. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
12. Becker L., Huang Q., and Mashimo H. Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue. Sci. World J. 8 (2008) 1168-1176
13. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., Jaenisch R., Wagschal A., Feil R., Schreiber S.L., and Lander E.S. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 (2006) 315-326
14. Bibikova M., Chudin E., Wu B., Zhou L., Garcia E.W., Liu Y., Shin S., Plaia T.W., Auerbach J.M., Arking D.E., Gonzalez R., Crook J., Davidson B., Schulz T.C., Robins A., Khanna A., Sartipy P., Hyllner J., Vanguri P., Savant-Bhonsale S., Smith A.K., Chakravarti A., Maitra A., Rao M., Barker D.L., Loring J.F., and Fan J.B. Human embryonic stem cells have a unique epigenetic signature. Genome Res. 16 (2006) 1075-1083
15. Bracken A.P., Dietrich N., Pasini D., Hansen K.H., and Helin K. Genome-wide mapping of polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 20 (2006) 1123-1136
16. Buisine M.P., Porchet N., and Van Seuningen I. Mucin expression and regulation during development and cell differentiation. In: van Seuningen I. (Ed). The Epithelial Mucins: Structure/Function. Roles in Cancer and Inflammatory Diseases (2008), Research Signpost, Kerala 75-94
17. Burger-van Paassen N., Vincent A., Puiman P.J., van der Sluis M., Bouma J., Boehm G., van Goudoever J.B., Van Seuningen I., and Renes I.B. The regulation of the intestinal mucin MUC2 expression by short chain fatty acids: implications for epithelial protection. Biochem. J. 420 (2009) 211-219
18. Buszczak M., Paterno S., and Spradling A.C. Drosophila stem cells share a common requirement for the histone H2B ubiquitin protease scrawny. Science 323 (2009) 248-251
19. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6 (2006) 857-866
20. Cano-Gauci D.F., Lualdi J.C., Ouellette A.J., Brady G., Iscove N.N., and Buick R.N. In vitro cDNA amplification from individual intestinal crypts: a novel approach to the study of differential gene expression along the crypt-villus axis. Exp. Cell Res. 208 (1993) 344-349
21. Chen L., and Daley G.Q. Molecular basis of pluripotency. Hum. Mol. Genet. 17 (2008) R23-R27
22. Collas P., Noer A., and Timoskainen S. Programming the genome in embryonic and somatic stem cells. J. Cell Mol. Med. 11 (2007) 602-620
23. Crosnier C., Stamataki D., and Lewis J. Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat. Rev. Genet. 7 (2006) 349-359
24. Dashwood R.H., and Ho E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin. Cancer Biol. 17 (2007) 363-369
25. De Marzo A.M., Marchi V.L., Yang E.S., Veeraswamy R., Lin X., and Nelson W.G. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res. 59 (1999) 3855-3860
26. de Santa Barbara P., van den Brink G.R., and Roberts D.J. Development and differentiation of the intestinal epithelium. Cell Mol. Life Sci. 60 (2003) 1322-1332
27. Dhir M., Montgomery E.A., Glockner S.C., Schuebel K.E., Hooker C.M., Herman J.G., Baylin S.B., Gearhart S.L., and Ahuja N. Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia. J. Gastrointest. Surg. 12 (2008) 1745-1753
28. Esteller M., Sparks A., Toyota M., Sanchez-Cespedes M., Capella G., Peinado M.A., Gonzalez S., Tarafa G., Sidransky D., Meltzer S.J., Baylin S.B., and Herman J.G. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 60 (2000) 4366-4371
29. Fodde R. The stem of cancer. Cancer Cell 15 (2009) 87-89
30. Fodde R., and Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr. Opin. Cell Biol. 19 (2007) 150-158
31. Fulka H., St John J.C., Fulka J., and Hozak P. Chromatin in early mammalian embryos: achieving the pluripotent state. Differentiation 76 (2008) 3-14
32. Godman C.A., Joshi R., Tierney B.R., Greenspan E., Rasmussen T.P., Wang H.W., Shin D.G., Rosenberg D.W., and Giardina C. HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling. Cancer Biol. Ther. 7 (2008) 1570-1580
33. Gonzalez S., Pisano D.G., and Serrano M. Mechanistic principles of chromatin remodeling guided by siRNAs and miRNAs. Cell Cycle 7 (2008) 2601-2608
34. Gratchev A., Siedow A., Bumke-Vogt C., Hummel M., Foss H.D., Hanski M.L., Kobalz U., Mann B., Lammert H., Mansmann U., Stein H., Riecken E.O., and Hanski C. Regulation of the intestinal mucin MUC2 gene expression in vivo: evidence for the role of promoter methylation. Cancer Lett. 168 (2001) 71-80
35. Grossmann J., Maxson J.M., Whitacre C.M., Orosz D.E., Berger N.A., Fiocchi C., and Levine A.D. New isolation technique to study apoptosis in human intestinal epithelial cells. Am. J. Pathol. 153 (1998) 53-62
36. Hahn M.A., Hahn T., Lee D.H., Esworthy R.S., Kim B.W., Riggs A.D., Chu F.F., and Pfeifer G.P. Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res. 68 (2008) 10280-10289
37. Hattori N., and Shiota K. Epigenetics: the study of embryonic stem cells by restriction landmark genomic scanning. FEBS J. 275 (2008) 1624-1630
38. He L., and Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5 (2004) 522-531
39. Heby O. DNA methylation and polyamines in embryonic development and cancer. Int. J. Dev. Biol. 39 (1995) 737-757
40. Hino K., Tsuchiya K., Fukao T., Kiga K., Okamoto R., Kanai T., and Watanabe M. Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation. RNA 14 (2008) 1433-1442
41. Hou L., and Hong T. Stem cells and neurodegenerative diseases. Sci. China C Life Sci. 51 (2008) 287-294
42. Houbaviy H.B., Murray M.F., and Sharp P.A. Embryonic stem cell-specific MicroRNAs. Dev. Cell 5 (2003) 351-358
43. Humphries A., and Wright N.A. Colonic crypt organization and tumorigenesis. Nat. Rev. Cancer 8 (2008) 415-424
44. Jackson M., Krassowska A., Gilbert N., Chevassut T., Forrester L., Ansell J., and Ramsahoye B. Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells. Mol. Cell. Biol. 24 (2004) 8862-8871
45. Johnston M.D., Edwards C.M., Bodmer W.F., Maini P.K., and Chapman S.J. Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. Proc. Natl. Acad. Sci. USA 104 (2007) 4008-4013
46. Jonckheere N., Vincent A., Perrais M., Ducourouble M.P., Male A.K., Aubert J.P., Pigny P., Carraway K.L., Freund J.N., Renes I.B., and Van Seuningen I. The human mucin MUC4 is transcriptionally regulated by caudal-related homeobox, hepatocyte nuclear factors, forkhead box A, and GATA endodermal transcription factors in epithelial cancer cells. J. Biol. Chem. 282 (2007) 22638-22650
47. Kastenberg Z.J., and Odorico J.S. Alternative sources of pluripotency: science, ethics, and stem cells. Transplant Rev. (Orlando) 22 (2008) 215-222
48. Kawai H., Tomii K., Toyooka S., Yano M., Murakami M., Tsukuda K., and Shimizu N. Promoter methylation downregulates CDX2 expression in colorectal carcinomas. Oncol. Rep. 13 (2005) 547-551
49. Keshet I., Schlesinger Y., Farkash S., Rand E., Hecht M., Segal E., Pikarski E., Young R.A., Niveleau A., Cedar H., and Simon I. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet. 38 (2006) 149-153
50. Kim J.Y., Beart R.W., and Shibata D. Stability of colon stem cell methylation after neo-adjuvant therapy in a patient with attenuated familial adenomatous polyposis. BMC Gastroenterol. 5 (2005) 19
51. Kim J.Y., Siegmund K.D., Tavare S., and Shibata D. Age-related human small intestine methylation: evidence for stem cell niches. BMC Med. 3 (2005) 10
52. Kim K.M., and Shibata D. Methylation reveals a niche: stem cell succession in human colon crypts. Oncogene 21 (2002) 5441-5449
53. Kirkwood T.B. Intrinsic ageing of gut epithelial stem cells. Mech. Ageing Dev. 125 (2004) 911-915
54. Klose R.J., and Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 8 (2007) 307-318
55. Lagarkova M.A., Volchkov P.Y., Lyakisheva A.V., Philonenko E.S., and Kiselev S.L. Diverse epigenetic profile of novel human embryonic stem cell lines. Cell Cycle 5 (2006) 416-420
56. Lagger G., O'Carroll D., Rembold M., Khier H., Tischler J., Weitzer G., Schuettengruber B., Hauser C., Brunmeir R., Jenuwein T., and Seiser C. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 21 (2002) 2672-2681
57. Lee M., Sup Han W., Kyoung Kim O., Hee Sung S., Sun Cho M., Lee S.N., and Koo H. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer. Pathol. Res. Pract. 202 (2006) 415-424
58. Leedham S.J., Brittan M., McDonald S.A., and Wright N.A. Intestinal stem cells. J. Cell Mol. Med. 9 (2005) 11-24
59. Leedham S.J., Thliveris A.T., Halberg R.B., Newton M.A., and Wright N.A. Gastrointestinal stem cells and cancer: bridging the molecular gap. Stem Cell Rev. 1 (2005) 233-241
60. Lengner C.J., Camargo F.D., Hochedlinger K., Welstead G.G., Zaidi S., Gokhale S., Scholer H.R., Tomilin A., and Jaenisch R. Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 1 (2007) 403-415
61. Li E., Bestor T.H., and Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69 (1992) 915-926
62. Liang J., Wan M., Zhang Y., Gu P., Xin H., Jung S.Y., Qin J., Wong J., Cooney A.J., Liu D., and Songyang Z. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 10 (2008) 731-739
63. Loh K., Chia J.A., Greco S., Cozzi S.J., Buttenshaw R.L., Bond C.E., Simms L.A., Pike T., Young J.P., Jass J.R., Spring K.J., Leggett B.A., and Whitehall V.L. Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. Genes Chromosomes Cancer 47 (2008) 449-460
64. Loh Y.H., Zhang W., Chen X., George J., and Ng H.H. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev. 21 (2007) 2545-2557
65. Lunyak V.V., and Rosenfeld M.G. Epigenetic regulation of stem cell fate. Hum. Mol. Genet. 17 (2008) R28-R36
66. Mancardi G., and Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet. Neurol. 7 (2008) 626-636
67. Mariadason J.M. HDACs and HDAC inhibitors in colon cancer. Epigenetics 3 (2008) 28-37
68. Marshman E., Booth C., and Potten C.S. The intestinal epithelial stem cell. Bioessays 24 (2002) 91-98
69. Martin K., Kirkwood T.B., and Potten C.S. Age changes in stem cells of murine small intestinal crypts. Exp. Cell Res. 241 (1998) 316-323
70. Mihara M., Yoshida Y., Tsukamoto T., Inada K., Nakanishi Y., Yagi Y., Imai K., Sugimura T., Tatematsu M., and Ushijima T. Methylation of multiple genes in gastric glands with intestinal metaplasia: a disorder with polyclonal origins. Am. J. Pathol. 169 (2006) 1643-1651
71. Monk M., Boubelik M., and Lehnert S. Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 99 (1987) 371-382
72. Monzo M., Navarro A., Bandres E., Artells R., Moreno I., Gel B., Ibeas R., Moreno J., Martinez F., Diaz T., Martinez A., Balague O., and Garcia-Foncillas J. Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res. 18 (2008) 823-833
73. Mori Y., Cai K., Cheng Y., Wang S., Paun B., Hamilton J.P., Jin Z., Sato F., Berki A.T., Kan T., Ito T., Mantzur C., Abraham J.M., and Meltzer S.J. A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterology 131 (2006) 797-808
74. Nicolas P., Kim K.M., Shibata D., and Tavare S. The stem cell population of the human colon crypt: analysis via methylation patterns. PLoS Comput. Biol. 3 (2007) e28
75. O'Shea K.S. Self-renewal vs. differentiation of mouse embryonic stem cells. Biol. Reprod. 71 (2004) 1755-1765
76. Ohm J.E., McGarvey K.M., Yu X., Cheng L., Schuebel K.E., Cope L., Mohammad H.P., Chen W., Daniel V.C., Yu W., Berman D.M., Jenuwein T., Pruitt K., Sharkis S.J., Watkins D.N., Herman J.G., and Baylin S.B. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 39 (2007) 237-242
77. Okano M., Bell D.W., Haber D.A., and Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99 (1999) 247-257
78. Omura N., Li C.P., Li A., Hong S.M., Walter K., Jimeno A., Hidalgo M., and Goggins M. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol. Ther. 7 (2008) 1146-1156
79. Pasini D., Bracken A.P., Hansen J.B., Capillo M., and Helin K. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol. Cell Biol. 27 (2007) 3769-3779
80. Phesse T.J., Parry L., Reed K.R., Ewan K.B., Dale T.C., Sansom O.J., and Clarke A.R. Deficiency of Mbd2 attenuates Wnt signaling. Mol. Cell. Biol. 28 (2008) 6094-6103
81. Pinto D., and Clevers H. Wnt, stem cells and cancer in the intestine. Biol. Cell 97 (2005) 185-196
82. Potten C.S., Booth C., Tudor G.L., Booth D., Brady G., Hurley P., Ashton G., Clarke R., Sakakibara S., and Okano H. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 71 (2003) 28-41
83. Radtke F., and Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 307 (2005) 1904-1909
84. Ribieras S., Lefebvre O., Tomasetto C., and Rio M.C. Mouse Trefoil factor genes: genomic organization, sequences and methylation analyses. Gene 266 (2001) 67-75
85. Ro S., and Rannala B. Methylation patterns and mathematical models reveal dynamics of stem cell turnover in the human colon. Proc. Natl. Acad. Sci. USA 98 (2001) 10519-10521
86. Robertson K.D. DNA methylation and human disease. Nat. Rev. Genet. 6 (2005) 597-610
87. Russo V.E.A., Martienssen R.A., and Riggs A.D. Epigenetic Mechanisms of Gene Regulation (1996), Cold Spring Harbor Laboratory Press, New York
88. Rybak A., Fuchs H., Smirnova L., Brandt C., Pohl E.E., Nitsch R., and Wulczyn F.G. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat. Cell Biol. 10 (2008) 987-993
89. Sangiorgi E., and Capecchi M.R. Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 40 (2008) 915-920
90. Santos-Rosa H., and Caldas C. Chromatin modifier enzymes, the histone code and cancer. Eur. J. Cancer 41 (2005) 2381-2402
91. Schlesinger Y., Straussman R., Keshet I., Farkash S., Hecht M., Zimmerman J., Eden E., Yakhini Z., Ben-Shushan E., Reubinoff B.E., Bergman Y., Simon I., and Cedar H. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet. 39 (2007) 232-236
92. Scoville D.H., Sato T., He X.C., and Li L. Current view: intestinal stem cells and signaling. Gastroenterology 134 (2008) 849-864
93. Segditsas S., Sieber O.M., Rowan A., Setien F., Neale K., Phillips R.K., Ward R., Esteller M., and Tomlinson I.P. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations. Exp. Mol. Pathol. 85 (2008) 201-206
94. Sharma R., and Raghubir R. Stem cell therapy: a hope for dying hearts. Stem Cells Dev. 16 (2007) 517-536
95. Shen X., Liu Y., Hsu Y.J., Fujiwara Y., Kim J., Mao X., Yuan G.C., and Orkin S.H. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol. Cell 32 (2008) 491-502
96. Suzuki T., Mochizuki K., and Goda T. Histone H3 modifications and Cdx-2 binding to the sucrase-isomaltase (SI) gene is involved in induction of the gene in the transition from the crypt to villus in the small intestine of rats. Biochem. Biophys. Res. Commun. 369 (2008) 788-793
97. Tanaka J., Watanabe T., Kanazawa T., Tada T., Kazama Y., Tanaka T., and Nagawa H. Silencing of secreted frizzled-related protein genes in MSI colorectal carcinogenesis. Hepatogastroenterology 55 (2008) 1265-1268
98. Tateishi K., Ohta M., Kanai F., Guleng B., Tanaka Y., Asaoka Y., Tada M., Seto M., Jazag A., Lianjie L., Okamoto M., Isayama H., Yoshida H., Kawabe T., and Omata M. Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract. Clin. Cancer Res. 12 (2006) 6960-6966
99. Taylor K.H., Kramer R.S., Davis J.W., Guo J., Duff D.J., Xu D., Caldwell C.W., and Shi H. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res. 67 (2007) 8511-8518
100. Tou L., Liu Q., and Shivdasani R.A. Regulation of mammalian epithelial differentiation and intestine development by class I histone deacetylases. Mol. Cell Biol. 24 (2004) 3132-3139
101. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A.P., Tjon-Pon-Fong M., Moerer P., van den Born M., Soete G., Pals S., Eilers M., Medema R., and Clevers H. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111 (2002) 241-250
102. van der Flier L.G., and Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu. Rev. Physiol 71 (2009) 241-260
103. van Es J.H., van Gijn M.E., Riccio O., van den Born M., Vooijs M., Begthel H., Cozijnsen M., Robine S., Winton D.J., Radtke F., and Clevers H. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435 (2005) 959-963
104. van Leeuwen I.M., Byrne H.M., Jensen O.E., and King J.R. Crypt dynamics and colorectal cancer: advances in mathematical modelling. Cell Prolif. 39 (2006) 157-181
105. Velcich A., Palumbo L., Jarry A., Laboisse C., Racevskis J., and Augenlicht L. Patterns of expression of lineage-specific markers during the in vitro-induced differentiation of HT29 colon carcinoma cells. Cell Growth Differ. 6 (1995) 749-757
106. Vincent A., Ducourouble M.P., and Van Seuningen I. Epigenetic regulation of the human mucin gene MUC4 in epithelial cancer cell lines involves both DNA methylation and histone modifications mediated by DNA methyltransferases and histone deacetylases. FASEB J. 22 (2008) 3035-3045
107. Vincent A., Perrais M., Desseyn J.L., Aubert J.P., Pigny P., and Van Seuningen I. Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. Oncogene 26 (2007) 6566-6576
108. Vincent, A., Van Seuningen, I., 2008. Mucins, epigenetics and cancer. In: van Seuningen, I. (Ed.), The Epithelial Mucins: Structure/Function. Roles in Cancer and Inflammatory diseases. Research Signpost, Kerala, pp. 95-108.
109. Visvader J.E., and Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8 (2008) 755-768
110. Walker M.R., and Stappenbeck T.S. Deciphering the 'black box' of the intestinal stem cell niche: taking direction from other systems. Curr. Opin. Gastroenterol. 24 (2008) 115-120
111. Wen B., Wu H., Shinkai Y., Irizarry R.A., and Feinberg A.P. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat. Genet. 41 (2009) 246-250
112. Wilson A.J., Byun D.S., Popova N., Murray L.B., L'Italien K., Sowa Y., Arango D., Velcich A., Augenlicht L.H., and Mariadason J.M. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem. 281 (2006) 13548-13558
113. Wong M.H., Huelsken J., Birchmeier W., and Gordon J.I. Selection of multipotent stem cells during morphogenesis of small intestinal crypts of Lieberkuhn is perturbed by stimulation of Lef-1/beta-catenin signaling. J. Biol. Chem. 277 (2002) 15843-15850
114. Xi J., and Zhang S.C. Stem cells in development of therapeutics for Parkinson's disease: a perspective. J. Cell Biochem. 105 (2008) 1153-1160
115. Xia M.H.P. Great potential of microRNA in cancer stem cell. J. Cancer Mol. 4 (2008) 79-89
116. Yatabe Y., Tavare S., and Shibata D. Investigating stem cells in human colon by using methylation patterns. Proc. Natl. Acad. Sci. USA 98 (2001) 10839-10844
117. Yen T.H., and Wright N.A. The gastrointestinal tract stem cell niche. Stem Cell Rev. 2 (2006) 203-212
118. Yeo S., Jeong S., Kim J., Han J.S., Han Y.M., and Kang Y.K. Characterization of DNA methylation change in stem cell marker genes during differentiation of human embryonic stem cells. Biochem. Biophys. Res. Commun. 359 (2007) 536-542
119. Zhang Y., Huang S., Dong W., Li L., Feng Y., Pan L., Han Z., Wang X., Ren G., Su D., Huang B., and Lu J. SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett. (2008)